AU3440697A - Topical composition comprising a combination of antihistaminic compounds with terpenoid compounds - Google Patents

Topical composition comprising a combination of antihistaminic compounds with terpenoid compounds

Info

Publication number
AU3440697A
AU3440697A AU34406/97A AU3440697A AU3440697A AU 3440697 A AU3440697 A AU 3440697A AU 34406/97 A AU34406/97 A AU 34406/97A AU 3440697 A AU3440697 A AU 3440697A AU 3440697 A AU3440697 A AU 3440697A
Authority
AU
Australia
Prior art keywords
compounds
combination
antihistaminic
topical composition
terpenoid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU34406/97A
Inventor
Beat Schmid
Werner Tschollar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GSK Consumer Healthcare SARL
Original Assignee
Novartis Consumer Health SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Consumer Health SA filed Critical Novartis Consumer Health SA
Publication of AU3440697A publication Critical patent/AU3440697A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU34406/97A 1996-07-02 1997-07-01 Topical composition comprising a combination of antihistaminic compounds with terpenoid compounds Abandoned AU3440697A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP96810436 1996-07-02
DE96810436 1996-07-02
PCT/EP1997/003421 WO1998000168A1 (en) 1996-07-02 1997-07-01 Topical composition comprising a combination of antihistaminic compounds with terpenoid compounds

Publications (1)

Publication Number Publication Date
AU3440697A true AU3440697A (en) 1998-01-21

Family

ID=8225640

Family Applications (1)

Application Number Title Priority Date Filing Date
AU34406/97A Abandoned AU3440697A (en) 1996-07-02 1997-07-01 Topical composition comprising a combination of antihistaminic compounds with terpenoid compounds

Country Status (7)

Country Link
EP (1) EP0910410A1 (en)
JP (1) JP2000515498A (en)
AU (1) AU3440697A (en)
CA (1) CA2258513A1 (en)
TR (1) TR199802769T2 (en)
WO (1) WO1998000168A1 (en)
ZA (1) ZA975902B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1073738T3 (en) * 1998-04-21 2005-01-24 Max Planck Gesellschaft Human K + ion channel and therapeutic applications thereof
PT1094781E (en) * 1998-07-07 2008-10-08 Transdermal Technologies Inc Compositions for rapid and non-irritating transdermal delivery of pharmaceutically active agents and methods for formulating such compositions and delivery thereof
US6284802B1 (en) 1999-04-19 2001-09-04 The Procter & Gamble Company Methods for regulating the condition of mammalian keratinous tissue
ATE272397T1 (en) * 1999-04-22 2004-08-15 Shiseido Co Ltd SELECTIVE ANTIBACTERIAL COMPOSITIONS
AU7398701A (en) * 2000-05-09 2001-11-20 Unilever Plc Cosmetic skin care compositions containing pulegone
AU2002229611A1 (en) * 2000-12-08 2002-06-18 Institut National De La Sante Et De La Recherche Medicale (Inserm) Use of active compounds capable of modulating the intracellular pathway triggered by the dp receptor in langerhans cells
US6750247B2 (en) 2001-05-31 2004-06-15 Galileo Laboratories, Inc. Sponge-derived terpenoids and methods of use
US6720423B2 (en) 2002-04-30 2004-04-13 Allergan, Inc. Dihydrobenzofuran and dihydrobenzothiophene 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors
JP4614638B2 (en) * 2002-06-07 2011-01-19 第一三共株式会社 Analgesic composition
JP2006527725A (en) * 2003-06-17 2006-12-07 ディーエスエム アイピー アセッツ ビー．ブイ． Topical drugs containing phytanic acid or its derivatives
GB0417909D0 (en) * 2004-08-11 2004-09-15 Novartis Consumer Health Sa Drop preparations
US7288263B2 (en) * 2004-09-13 2007-10-30 Evera Laboratories, Llc Compositions and methods for treatment of skin discoloration
US20090264664A1 (en) * 2005-10-21 2009-10-22 Medrx Co., Ltd. Preparation for external application comprising salt of mast cell degranulation inhibitor having carboxyl group with organic amine
WO2007110380A1 (en) * 2006-03-25 2007-10-04 Boehringer Ingelheim International Gmbh Insect bite relief preparation comprising epinastine
US20090136430A1 (en) * 2007-11-27 2009-05-28 Dugger Harry A Antihistamine/Corticosteroid preparations for the treatment of atopic dermatitis
CN101390830B (en) * 2008-11-12 2011-05-18 常州市第四制药厂有限公司 Anarexol cream and preparation method thereof
JP5912238B2 (en) * 2010-09-30 2016-04-27 小林製薬株式会社 Emulsified composition
ES2598753T3 (en) 2012-11-27 2017-01-30 Eduardo Cos Alfonso Pharmaceutical composition for the treatment of calcified tendinitis and / or calcified bursitis
AU2014211953B2 (en) 2013-02-01 2018-08-02 Ddrops Company Liquid menthol compositions
JP6537775B2 (en) * 2014-03-10 2019-07-03 小林製薬株式会社 Emulsified composition
WO2018063876A1 (en) * 2016-09-30 2018-04-05 Alpha To Omega Pharmaceutical Consultants, Inc. Transdermal and/or topical delivery systems comprising cetirizine dihydrochloride

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59122420A (en) * 1982-12-28 1984-07-14 Otsuka Pharmaceut Factory Inc Local ointment
EP0158090B1 (en) * 1984-03-07 1990-08-29 Roshdy Dr. Ismail Drug for the treatment and the protection of the skin
JPS62205019A (en) * 1986-03-03 1987-09-09 Kao Corp Drug for external use
IL88076A (en) * 1987-10-28 1993-01-14 Nippon Shinyaku Co Ltd Fat emulsions as drug carriers
WO1989012626A1 (en) * 1988-06-24 1989-12-28 Stephen Herman Ozonides of terpenes and their medical uses
US5057500A (en) * 1990-02-12 1991-10-15 Dermatologic Research Corporation Treatment of pruritis with esters and amides
JPH04154719A (en) * 1990-10-19 1992-05-27 Hiroshi Kikuchi Athlete's foot drug
WO1992013540A1 (en) * 1991-02-06 1992-08-20 Guy Parent Antalgic ointment
JPH05286860A (en) * 1992-04-03 1993-11-02 Kowa Co Gel ointment
WO1994008550A1 (en) * 1992-10-09 1994-04-28 The Procter & Gamble Company Anaesthetic compositions

Also Published As

Publication number Publication date
JP2000515498A (en) 2000-11-21
TR199802769T2 (en) 1999-04-21
CA2258513A1 (en) 1998-01-08
ZA975902B (en) 1999-01-04
WO1998000168A1 (en) 1998-01-08
EP0910410A1 (en) 1999-04-28

Similar Documents

Publication Publication Date Title
AU3440697A (en) Topical composition comprising a combination of antihistaminic compounds with terpenoid compounds
AU2162597A (en) A novel composition, its preparation and use
AU4464196A (en) Retroreflective composition
AU5136998A (en) Medicinal composition
AU7002296A (en) Analgesic composition
AUPO688997A0 (en) Sunscreen composition
AU4147393A (en) A grout composition
AU3308195A (en) Antihypertriglyceridemic composition
AU9663498A (en) Sunscreen composition
AU2310395A (en) Topical retinal-based composition
AU5882298A (en) New analgesic composition
AU2953497A (en) Topical composition
AU1658997A (en) Topical composition
AU2783092A (en) Composition for topical application
AU2967797A (en) Topical pediculicidal compositions
AU2813195A (en) Composition
GB9612417D0 (en) A topical composition
AU3886395A (en) A marking composition
AUPM939694A0 (en) Topical preparation
AU2264697A (en) Therapeutic compositions containing a hexahydro-5-pyrimidinamine compound and a morpholine-ether compound
AU665104B2 (en) A hydromulch composition
AU7226894A (en) A stable composition
AU3291295A (en) Composition
AUPO850997A0 (en) Topical composition
AUPO919897A0 (en) Analgesic composition